Abstract. Bauhinia championi (Benth.) Benth. polysaccharides (BCBPs), extracted from Bauhinia championi (Benth.) Benth., which has been used in traditional Chinese medicine (TCM) for the treatment of osteoarthritis (OA), are the bioactive constituents of Bauhinia championi (Benth.) rattan. However, the molecular mechanisms responsible for their effects on OA are poorly understood. The Wnt/β-catenin signaling pathway plays an important role in the proliferation of chondrocytes. In the present study, the effects of BCBPs on Wnt/β-catenin signaling in chondrocytes were investigated. BCBPs were obtained by hot-water extraction and identified by the modified high performance liquid chromatography (HPLC) method. Chondrocytes were isolated from the knees of Sprague-Dawley rats and identified by type II collagen immunohistochemistry. The chondrocytes were treated with or without BCBPs for 48 h. Cell viability was evaluated by MTT assay. The mRNA and protein levels of Wnt-4, β-catenin, Frizzled-2, glycogen synthase kinase (GSK)-3β, cyclin D1 and collagen II were detected by western blot analysis and reverse transcription PCR (RT-PCR), respectively. We found that the BCBPs contained at least seven monosaccharides, including D-mannose, rhamnose, D-(+) glucuronic acid, D-(+) galacturonic acid, D-glucose, galactose and arabinose. The cell viability of the chondrocytes treated with 50, 100 and 200 µg/ml BCBPs was significantly higher than that of the chondroctyes in the control group (treated with 0 µg/ml BCBPs). Furthermore, compared with the control group, the mRNA and protein expression of Wnt-4, β-catenin, Frizzled-2 and cyclin D1 in the BCBP-treated groups markedly increased, whereas the mRNA and protein expression of GSK-3β significantly decreased. Of note, the dose of 100 µg/ml BCBPs was more effective than the dose of 50 µg/ml BCBPs and 200 µg/ml BCBPs. In addition, we found that treatment with BCBPs upregulated the protein levels of collagen II in the chondrocytes. These results indicate that BCBPs upregulate Wnt/β-catenin signaling, thus promoting chondrocyte proliferation.
Introduction
Osteoarthritis (OA), a common disease in many middleto-old-aged individuals, can cause pain and disability. The imbalance of cartilage matrix synthesis and degradation are the main pathological manifestations of OA, resulting in cartilage degeneration (1) . Chondrocytes are the single cell type in cartilage which express cartilage-specific proteins, such as type II collagen and proteoglycans (2) . Hence, enhancing chondrocyte function by promoting chondrocyte proliferation may prove to be beneficial in delaying the progression of cartilage degradation.
The Wnt signaling pathway plays an important role in the regulation of proliferation (3), differentiation and apoptosis (4) . The Wnt protein binds to Frizzled family receptors and low density lipoprotein receptor-related protein (LRP)5/6 can activate the Wnt signaling pathway, which results in the activation of dishevelled (Dvl) family proteins. The activation of Dvl leads to the inhibition of glycogen synthase kinase (GSK)-3β. Without Wnt signaling, GSK-3β is thought to phosphorylate and consequently induce the degradation of β-catenin (5) . When the kinase activity of GSK-3β is suppressed, nonphosphorylated β-catenin can accumulate in the cytoplasm and migrate to the nucleus, where it interacts with the T-cell factor (TCF)/lymphoid enhancer factor (LEF) family of transcription factors, thus altering the expression of Wnt signaling target genes (6, 7) , such as cyclin D1, which plays a key role in the G1/S transition in the cell cycle and is a positive regulator of the G1/S transition (8) .
Bauhinia championi (Benth.) (BCB), a dicotyledonous plant from the genus Bauhinia (Leguminosae), has been used Analysis of monosaccharide composition. BCBPs (20 mg) were hydrolyzed with 1 ml 4 M trifluoroacetic acid (TFA) at 110˚C for 2 h in a small sealed ampoule filled with nitrogen. After being returned to room temperature, the hydrolysate was neutralized with 0.6 M NaOH. A total of 200 µl of stocked standard solution (2 mg/ml) or hydrolyzed BCBP solution was mixed with 200 µl 0.6 M NaOH and 400 µl 0.4 M methanol solution of 1-phenyl-3-methyl-5-pyrazolone (PMP), and kept in a water bath at 90˚C for 70 min. After being cooled to room temperature, 0.3 M HCl (400 µl) were added and allowed to react with the mixture. Finally, each resulting solution was extracted with 1 ml chloroform three times and filtered through a 0.45-µm membrane for high performance liquid chromatography (HPLC). BCBPs were analyzed on a HPLC system (Agilent 1200; Agilent Technologies, Santa Clara, CA, USA), an Ultimate™ XB-C18 column (4.6x250 mm, 5 µm; Welch Materials Inc., Ellicott City, MD, USA) and a UV detector. The analysis conditions were as follows: mobile phase A:B, 82:18 (A, 0.1 M phosphate buffer; B, acetonitrile); pH 6.7; flow rate, 1.0 ml/ min; injection volume, 20 µl; UV detector, WL 245 nm; column temperature, 30˚C. D-mannose (Man), rhamnose (Rham), D-(+) glucuronic acid (GluUA), D-(+) galacturonic acid (GalUA), D-glucose anhydrous (Glc), galactose (Gal) and arabinose (Ara) were analyzed as the standard substances, as previously described (17) .
Isolation, culture and identification of chondrocytes. The SD rats were sacrificed by cervical dislocation and the bilateral knee joints were peeled off under sterile conditions. The articular cartilage was cut out, and rinsed three times in PBS (HyClone, Logan, UT, USA) containing penicillin and streptomycin. The cartilage was cut into 1 mm 3 sections, transferred onto a dish with 0.2% collagenase II (Sigma, St. Louis, MO, USA) and incubated in a 37˚C 5% CO 2 incubator. Supernatant fluid was collected every 1.5 h, then centrifuged for 5 min (1,000 rpm), and the precipitate was resuspended in DMEM containing 10% FBS, 50 mg/l vitamin C, 100 U/ml penicillin and 100 µg/ml streptomycin (HyClone). The cells were cultured in a 25 mm 2 culture flask and placed in a 37˚C 5% CO 2 incubator after adjusting the cell density (3x10 5 /ml; termed P0). The cells were subcultured when they reached 80-90% confluence, as determined under a microscope. Subcequently these cells were named P1, P2 and P3, as previously described (18) . The P2 chondrocytes were identified by type II collagen immunohistochemistry.
Cell viability assay. A total of 100 µl 5x10 4 /ml chondrocytes were plated in a 96-well and cultured for 24 h. They were then treated with 0, 50, 100 and 200 µg/ml BCBPs for 48 h. Subsequently, 20 µl 0.5% MTT (Sigma) were added to each well, followed by incubation for 4 h at 37˚C. The purple-blue MTT was dissolved in 150 µl DMSO with shaking for 10 min. The absorbance was measured at 490 nm on an ELISA plate reader (Model EXL800; BioTeK, Winooski, VT, USA).
Western blot analysis. Following treatment with BCBPs, protein was extracted from chondrocytes using lysis buffer on ice, and protein was then measured using the BCA assay. Protein (20 µg) was separated on a 10% SDS-PAGE gel and transferred onto PVDF membranes. The membranes were blocked for 3 h at room temperature in 5% non-fat dried milk, and incubated with primary antibodies against Wnt-4, β-catenin, Frizzled-2 (Santa Cruz Biotechnology, Inc., CA, USA), GSK-3β (Cell Signaling Technology, Inc., Beverly, MA, USA ), cyclin D1, collagen II (Bio-Word Technology, Natong, China) and β-actin (Santa Cruz Biotechnology, Inc.) overnight at 4˚C with rocking. The membranes were incubated horseradish peroxidase (HRP)-conjugated secondary antibody (Zhongshan Goldenbridge Biotech, Beijing, China) at room temperature. The ECL method was used to make the signal visible and β-actin was used as the internal control.
RNA extraction and reverse transcription PCR (RT-PCR).
Total RNA was isolated using TRIzol reagent (Invitrogen, Grand Island, NY, USA). RNA (1 µg) was reverse transcribed to cDNA according to the instructions provided by the manufacturer. The obtained cDNA was used to determine the expression of Wnt-4, β-catenin, Frizzled-2, GSK-3β, cyclin D1 and collagen II; β-actin was used as an internal control. The primers used for PCR are presented in Table I . The conditions use for PCR were as follows: 94˚C for 4 min, 94˚C for 30 sec, 57˚C/60˚C/58˚C/60˚C/55˚C/63˚C/60˚C for 45 sec, 72˚C for 45 sec, for 35 cycles. The samples were analyzed by gel electrophoresis (1.5% agarose) and were examined using a Gel Documentation System (Model Gel Doc 2000; Bio-Rad, Hercules, CA, USA).
Statistical analysis. Data are the means of three measurements and are expressed as the means ± standard deviation. The data were processed using the PASW package for Windows (version 18.0). Statistical analysis of the data was performed using the Student's t-test and ANOVA. Values of P<0.05 were considered to indicate statistically significant differences.
Results
Monosaccharide composition of BCBPs. By comparing the retention time of unknown peaks to peaks in the standard samples (Fig. 1B) , the BCBPs monosaccharide composition was identified (Fig. 1A) , and contained at least seven monosaccharides, including Man, Rham, GluUA, GalUA, Glc, Gal and Ara. Among these, the contents of Ara and Gal were higher than those of the other monosaccharides; the content of Ara was the highest, while the separation of Rham, GluUA, GalUA, Glc, Gal and Ara was easier than that of Man. 
Morphological observation and identification of chondrocytes.
The primary chondrocytes resembled small balls when first suspended in DMEM. After 24 h, the majority of the cells were nestled against the culture flask, and their volumes became larger ( Fig. 2A and B) . Three days later, the cells grew to be tufted (Fig. 2C) . The cells had typical characteristics of chondrocytes, having a 'flagstone' pattern ( Fig. 2D ) when confluent in a single cell layer. The P2 and P3 chondrocytes grew much more rapidly and became confluent cells within four to five days ( Fig. 2E and F) . Collagen type II, one of the main secreted proteins in the chondrocyte extracellular matrix, has been commonly used for the identification of chondrocytes by immunohistochemistry. The cytoplasm stained brown represented the positive expression in chondrocytes.
BCBPs promote chondrocyte viability. Chondrocyte viability was detected by MTT assay. As shown in Fig. 3 (Fig. 4) . The mRNA expression levels of GSK-3β, Wnt-4, β-catenin, Frizzled-2, cyclin D1 and collagen II were similar to their respective protein levels (Fig. 5) . Taken together, our results indicate that BCBPs upregulate the protein and mRNA levels of Wnt-4, β-catenin, Frizzled-2, cyclin D1 and collagen II, and downregulate the levels of GSK-3β.
Discussion
The Wnt/β-catenin signaling pathway plays an important role in a number of cellular events, such as cell proliferation, migration and differentiation. The activation of this pathway in different cells and the consequences of such an activation have been extensively discussed. A number of studies have reported that the Wnt/β-catenin signaling pathway is necessary for normal and abnormal cell proliferation, such as neural progenitor cells (20) , glial cells (21) and a variety of of tumor cells (22) .
A number of studies have demonstrated that the Wnt/β-catenin signaling pathway is closely related to cartilage function, including cartilage development, chondrocyte differentiation and plays an important role in the progression of OA (23, 24) . In this study, our results revealed that BCBPs upregulated the protein and mRNA expression of Wnt-4, β-catenin, Frizzled-2, cyclin D1 and collagen II, whereas BCBPs downregulated GSK-3β expression levels, suggesting that BCBPs activate the Wnt/β-catenin signaling pathway, thus promoting chondrocyte proliferation.
Currently, the therapeutic strategies for OA are exercise combined with the use of analgesics and non-steroidal antiinflammatory drugs (25) ; however, these treatments only focus on alleviating the symptoms, which are mainly pain and inflammation, and fail to obtain good results. Non-steroidal anti-inflammatory drugs have several side-effects, such as gastrointestinal-related toxicities and cardiovascular risks. Corticosteroids are also applied for the treatment of OA, but their substantial toxicities limit long term usage. Chinese herbs have been used in the treatment of OA for thousands of years (26) . BCBPs, extracted from BCB are one of the main effective elements used for OA therapy.
Chondrocytes, the only cell type that is present in mature cartilage, are important to maintain the balance of cartilage matrix synthesis, as well as the function of the articular cartilage. In recent years, certain studies have demonstrated that osteoarthritic chondrocytes have a low proliferative activity (27, 28) . Thus, promoting chondrocyte proliferation may be an efficient method for the treatment of OA. In our previous study, we demonstrated that BCBPs promoted chondrocyte proliferation (19) ; however, the precise molecular mechanisms responsible for the effects of BCBPs on chondrocyte proliferation have not yet been fully elucidated. In this study, we investigated the mechanisms responsible for the effects of BCBPs on the Wnt/β-catenin signaling pathway in chondrocytes to build a scientific foundation for the use of BCBPs in the treatment of OA.
The Wnt/β-catenin signaling pathway plays a crucial role in the processes of cell proliferation and differentiation (29) , the early stage of cartilage formation, chondrocyte differentiation and endochondral bone formation. The key factor of the Wnt/β-catenin signaling pathway is the stable accumulation of β-catenin in the cytosol and its transfer to the nucleus, binding to the transcription factors, TCF and LEF. These factors regulate the expression of cyclin D1, which is an important factor in cell proliferation and differentiation (30) . The activation of the Wnt/β-catenin signaling pathway activates cyclin D1, accelerating cell cycle progression. Our results demonstrated that BCBPs increased chondrocyte viability, and significantly upregulated the protein and mRNA expression of Wnt-4, Frizzled-2 and β-catenin in the chondrocytes, whereas the expression of GSK-3β in the chondrocytes was significantly downregulated, suggesting that the BCBPs activated the Wnt/β-catenin signaling pathway by inhibiting the activity of GSK-3β, causing non-phosphorylated β-catenin accumulation and transfer to the nucleus, where it interacts with TCF/LEF to enhance the expression of cyclin D1.
In conclusion, our results demonstrated that the activation of the Wnt/β-catenin signaling pathway induced by treatment with BCBPs contributed to chondrocyte proliferation. Apart from the Wnt/β-catenin signaling pathway, there are multiple signaling pathways controlling the proliferation of chondrocytes. Hence, additional studies are required to explore the cross-talk function of the signaling pathways during the process of chondrocyte proliferation.
